CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $3.29M invested in CASI Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

36% less capital invested

Capital invested by funds: $5.17M → $3.29M (-$1.88M)

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$41.6K
2
+$2.38K
3
+$917
4
Vanguard Group
Vanguard Group
Pennsylvania
+$313
5
WPA
West Paces Advisors
Georgia
+$179

Top Sellers

1
-$200K
2
-$29K
3
-$21.7K
4
Morgan Stanley
Morgan Stanley
New York
-$3.63K
5
UBS Group
UBS Group
Switzerland
-$2.98K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.58M
2
$461K
3
$369K
4
$260K
5
$171K
6
$164K
7
$100K
8
$62.2K
9
$45.8K
10
$43K
11
$20K
12
$7K
13
$3.48K
14
$2.55K
15
$1K
16
$179
17
$111
18
$23
19
$21
20
$21
21
$20
22
–
23
–